Esperion Theraptc (ESPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 25,786 | 24,329 | 18,818 | 18,980 | 18,841 |
| Cost of Goods | 6,786 | 11,652 | 4,160 | 6,506 | 9,176 |
| Gross Profit | 19,000 | 12,677 | 14,658 | 12,474 | 9,665 |
| Operating Expenses | 56,844 | 61,934 | 57,331 | 54,603 | 62,217 |
| Operating Income | -37,058 | -48,605 | -42,513 | -41,623 | -52,376 |
| Interest Expense | 14,537 | 14,387 | 14,329 | 14,153 | 14,266 |
| Other Income | 1,660 | 1,273 | 1,355 | 659 | 318 |
| Pre-tax Income | -49,935 | -61,719 | -55,487 | -55,117 | -66,324 |
| Net Income Continuous | -49,935 | -61,719 | -55,487 | -55,117 | -66,324 |
| Net Income | $-49,935 | $-61,719 | $-55,487 | $-55,117 | $-66,324 |
| EPS Basic Total Ops | -0.46 | -0.79 | -0.73 | -0.81 | -1.05 |
| EPS Basic Continuous Ops | -0.46 | -0.79 | -0.73 | -0.81 | -1.05 |
| EPS Diluted Total Ops | -0.46 | -0.79 | -0.73 | -0.81 | -1.05 |
| EPS Diluted Continuous Ops | -0.46 | -0.79 | -0.73 | -0.81 | -1.05 |
| EBITDA(a) | $-36,658 | $-48,446 | $-42,267 | $-40,944 | $-51,625 |